Attached files
| file | filename |
|---|---|
| EX-32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex32-1.htm |
| EX-31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex31-1.htm |
| EX-21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex21-1.htm |
| EX-31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex31-2.htm |
| EX-23.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex23-1.htm |
| EX-24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_ex24-1.htm |
| 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | v179145_10k.htm |
Exhibit
32.2
CERTIFICATION
OF PERIODIC FINANCIAL REPORT PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002, 18 U.S.C. SECTION 1350
The undersigned hereby certifies that
he is the duly appointed and acting Chief Financial Officer of Neoprobe
Corporation (the Company) and hereby further certifies as follows:
(1) The
periodic report containing financial statements to which this certificate is an
exhibit fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the periodic report to which this certificate is an
exhibit fairly presents, in all material respects, the financial condition and
results of operations of the Company.
In witness whereof, the undersigned has
executed and delivered this certificate as of the date set forth opposite his
signature below.
|
March
31, 2010
|
/s/ Brent L. Larson
|
|
Brent
L. Larson
|
|
|
Vice
President, Finance and
|
|
|
Chief
Financial Officer
|